This morning Evernow, a digital ladies’s well being firm, named Dr. Leah Millheiser its subsequent chief medical officer. Millheiser is a educated OB/GYN who focuses on menopause and sexual well being. She is a scientific professor and the director of the Feminine Sexual Medication Program within the Division of Obstetrics and Gynecology at Stanford Medical Middle.
Dr. Jennifer Garrison, co-founder and director of the World Consortium for Feminine Reproductive Longevity & Equality, can also be becoming a member of the corporate as Scientific Advisor. Moreover, Dr. Sonali Sharma, an grownup psychiatrist and co-host of the podcast Mannequin Mentality, will now sit on the Medical Advisory Board.
“We’re tremendously excited to welcome Dr. Millheiser, Dr. Sharma and Dr. Garrison to our firm,” Alicia Jackson, CEO of Evernow, mentioned in an announcement. “As we scale out our enterprise and plan for 2022, we want targeted leaders who can proceed to hold on our mission to assist and enhance ladies’s healthcare and keep it up the expansion of our firm.”
Carrot Fertility, a reproductive-benefits supervisor, tapped Tim Kelly as its subsequent chief business officer. Kelly involves Carrot after serving at Aetna for 15 years. His work additionally features a stint at UnitedHealth Group, the place he served as a gross sales government.
The corporate additionally introduced that it’s selling Brooke Quinn, senior vice chairman of buyer success, to chief buyer officer, and James Wong, vice chairman of product, to chief product officer.
This information comes simply months after the corporate nabbed $75 million in Series C funding.
“Our mission has all the time been to make fertility healthcare accessible for everybody, starting within the office,” Dr. Asima Ahmad, co-founder and chief medical officer, mentioned in an announcement. “From scientific care navigation to engineering, product, buyer success and past, we have constructed a world-class staff that is arduous at work creating extra equitable entry to fertility care and family-forming choices for our members.”
Zerigo, maker of a linked phototherapy gadget for pores and skin circumstances, named Helen Calvin its subsequent president and chief business officer. On this new function, she is anticipated to steer the corporate’s business operations and technique features.
Calvin comes from Jellyvision, the place she served as chief income and development officer.
“I’m thrilled to hitch Zerigo Well being at such an thrilling time for the corporate, in addition to the digital well being business,” mentioned Calvin. “Our skill to provide members the instruments and help to manage their very own prescription remedy, the place and when they need, represents the way forward for persistent illness administration.
“The response from well being plans and employers has been extremely robust. These firms have been searching for an economical and clinically confirmed answer to supply their members and workers to deal with persistent pores and skin issues. They’re assured they’ve discovered the answer in Zerigo.”
In October, Zerigo made information when it introduced a $43 million Series B funding round.
H1, a healthcare supplier knowledge community, appointed Mike Derezin to its Board of Administrators. Derezin is the COO for Chainlink Labs, and has beforehand labored at LinkedIn, VoxPop and Porvenir.
“Mike Derezin is an thrilling addition to our Board,” mentioned Ariel Katz, co-founder and CEO of H1. “There are some necessary similarities between H1 and the early days of LinkedIn. As our world healthcare community expands, Mike’s expertise at LinkedIn, in addition to his experience in scaling companies as a profitable CEO and a trusted investor to startups shall be invaluable. I’m grateful to have him on our staff at this pivotal second for our firm.”
In November, H1 raked in a whopping $100 million in Series C funding. Later that month, the corporate introduced that Ziad Ismail would be its next chief operating officer.